Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.725 | 1.725 | 1.725 | 0 | 0 | CS |
4 | 0 | 0 | 1.725 | 1.725 | 1.725 | 0 | 0 | CS |
12 | 0 | 0 | 1.725 | 1.725 | 1.725 | 0 | 0 | CS |
26 | -4.095 | -70.3608247423 | 5.82 | 6.15 | 1.1 | 51479 | 1.77256834 | CS |
52 | -9.225 | -84.2465753425 | 10.95 | 14.33697 | 1.1 | 115792 | 6.71618357 | CS |
156 | -212.775 | -99.1958041958 | 214.5 | 300.639 | 1.1 | 402707 | 113.2728078 | CS |
260 | -345.975 | -99.5038826575 | 347.7 | 474.6 | 1.1 | 365986 | 178.53654648 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.